Larger molecules based on antibody scaffolds and fragments, including PF-05231023 (190 kDa), BFKB8488A and MK-3655 (150 kDa), and efruxifermin (92 kDa) may be less likely to cross the blood-brain barrier at therapeutic doses, but their tissue distribution has not been described
The number of people who could choose to use a weight-loss drug or a GLP-1, its a really big group of people, Handel said
doi: 10.1136/bmj-2023-076197 26 HigginsJPThompsonSGDeeksJJAltmanDG
A hybrid two-component system protein of a prominent human gut symbiont couples glycan sensing in vivo to carbohydrate metabolism
Before this approval, generic liraglutide was only approved to treat people with Type 2 diabetes, as a generic version of brand-name Victoza
Ginsenoside rg1 regulates liver lipid factor metabolism in nafld model rats